姓名:許耀峻  Yao-Chun Hsu    科別:胃腸肝膽科    論文篇數: 41


AuthorTitleSourceYear
Kao FC, Hsu YC, Chen WH, Lin JN, Lo YY, Tu YK.Prosthetic Joint Infection Following Invasive Dental Procedures and Antibiotic Prophylaxis in Patients With Hip or Knee Arthroplasty.Infect Control Hosp Epidemiol. 2017 Feb;38(2):154-161. doi: 10.1017/ice.2016.248. Epub 2016 Nov 9.2017
Hsu YC, Mo LR, Chang CY, Wu MS, Yang TH, Kao JH, Chen CC, Tseng CH, Tai CM, Lin CW, Wu CY, Lin JT.Serum viral load at the virological relapse predicts subsequent clinical flares in chronic hepatitis B patients off entecavir therapy.J Gastroenterol Hepatol. 2017 Jan 25. doi: 10.1111/jgh.13728. [Epub ahead of print]2017
Kao FC, Hsu YC, Lin CJ, Lo YY, Tu YK.Corticosteroid Is Associated with Both Hip Fracture and Fracture-Unrelated Arthropathy.PLoS One. 2017 Jan 26;12(1):e0169468. doi: 10.1371/journal.pone.0169468. eCollection 2017.2017
Tseng CM, Huang SP, Liao WC, Chiang CJ, Yang YW, Chang CY, Hsu YC, Chen HC, Chiang HS, Lin JT.Incidence and mortality of pancreatic cancer on a rapid rise in Taiwan, 1999-2012.Cancer Epidemiol. 2017 Jun 7;49:75-84. doi: 10.1016/j.canep.2017.05.011. [Epub ahead of print]2017
Liou JM, Fang YJ, Chen CC, et al.Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.Lancet. 2016 Nov 12;388(10058):2355-2365. doi: 10.1016/S0140-6736(16)31409-X. Epub 2016 Oct 18.2016
Tseng CM, Chen TB2, Hsu YC, Chang CY, Lin JT, Mo LR.Comparative effectiveness of nucleos(t)ide analogues in chronic hepatitis B patients undergoing cytotoxic chemotherapy.Asia Pac J Clin Oncol. 2016 Dec;12(4):421-429. doi: 10.1111/ajco.12520. Epub 2016 Jul 20.2016
Chen CC, Hsu YC, Lee CT, Hsu CC, Tai CM1, Wang WL, Tseng CH, Hsu CT, Lin JT, Chang CY.Central Obesity and H. pylori Infection Influence Risk of Barrett's Esophagus in an Asian Population.PLoS One. 2016 Dec 9;11(12):e0167815. doi: 10.1371/journal.pone.0167815. eCollection 2016.2016
Wu CY, Hsu YC, Ho HJ, Chen YJ, Lee TY, Lin JT.Association between ultrasonography screening and mortality in patients with hepatocellular carcinoma: a nationwide cohort study.Gut. 2016 Apr;65(4):693-701. doi: 10.1136/gutjnl-2014-308786. Epub 2015 Feb 10.2016
Liou JM, Fang YJ, Chen CC, et al.Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.Lancet. 2016 Oct 18. pii: S0140-6736(16)31409-X. doi: 10.1016/S0140-6736(16)31409-X. [Epub ahead of print]2016
Kao FC, Hsu YC, Yen CY, Lin CJ, Wu CH, Tu YK.Revision and Survival Rates After Total Knee Arthroplasty in Individuals Aged 70 and Older.J Am Geriatr Soc. 2016 Nov;64(11):e225-e227. doi: 10.1111/jgs.14456. Epub 2016 Sep 19.2016
Hsu YC, Mo LR, Chang CY, Wu MS, Kao JH, Wang WL, Yang TH, Wang CS, Chiang MF, Chen CC, Fang YJ, Hung HW, Wu CY, Lin JT.Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen-Negative Patients.Clin Gastroenterol Hepatol. 2016 Oct;14(10):1490-1498.e3. doi: 10.1016/j.cgh.2016.03.024. Epub 2016 Mar 24.2016
Hsu YC, Wu CY, Lin JT.Hepatitis C Virus Infection, Antiviral Therapy, and Risk of Hepatocellular Carcinoma.Semin Oncol. 2015 Apr;42(2):329-338. doi: 10.1053/j.seminoncol.2014.12.023. Epub 2014 Dec 31.2015
Hsu YC, Wu CY.Reply.Gastroenterology. 2015 Jun 29. pii: S0016-5085(15)00893-8. doi: 10.1053/j.gastro.2015.06.034. [Epub ahead of print]2015
Wang WL, Wang YC, Lee CT, Chang CY, Lo JL, Kuo YH, Hsu YC, Mo LR.The impact of human papillomavirus infection on the survival and treatment response of patients with esophageal cancers.J Dig Dis. 2015 May;16(5):256-63. doi: 10.1111/1751-2980.12236.2015
Tsai MS, Hsu YC, Yu PC, Lin CL, Kao CH.Long-term risk of acute coronary syndrome in hepatitis C virus infected patients without antiviral treatment: A cohort study from an endemic area.Int J Cardiol. 2015 Feb 15;181:27-9. doi: 10.1016/j.ijcard.2014.11.200. Epub 2014 Nov 27.2015
Hsu YC, Ho HJ, Huang YT, Wang HH, Wu MS, Lin JT, Wu CY.Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection.Gut. 2015 Mar;64(3):495-503. doi: 10.1136/gutjnl-2014-308163. Epub 2014 Nov 14.2015
Hsu YC, Lin HJ.Intermittent bolus or continuous infusion of proton pump inhibitors for ulcer bleeding?JAMA Intern Med. 2015 Mar 1;175(3):461. doi: 10.1001/jamainternmed.2014.7797.2015
Lo GH, Lin CW, Hsu YC.A controlled trial of early versus delayed feeding following ligation in the control of acute esophageal variceal bleedingJ Chin Med Assoc. 2015 Nov;78(11):642-7. doi: 10.1016/j.jcma.2015.07.004. Epub 2015 Sep 2.2015
Liou JM, Chen CC, Chang CY, et al.Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: a randomised trial.Gut. 2015 Sep 3. pii: gutjnl-2015-310142. doi: 10.1136/gutjnl-2015-310142. [Epub ahead of print]2015
Yao-Chun HsuAnalyzing Taiwan's National Health Insurance Research Database to explicate the allocation of health-care resourcesAdvances in Digestive Medicine. 2015:2:41-43.2015
Fang YJ, Liou JM, Chen CC, Lee JY, Hsu YC, Chen MJ, Tseng PH, Chen CC, Chang CY, Yang TH, Chang WH, Wu JY, Wang HP, Luo JC, Lin JT, Shun CT, Wu MS; Taiwan Gastrointestinal Disease and Helicobacter Consortium.Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria.Gut. 2015 Oct;64(10):1517-28. doi: 10.1136/gutjnl-2014-308114. Epub 2014 Nov 18.2015
Hsu YC, Lin HJ.Intermittent bolus or continuous infusion of proton pump inhibitors for ulcer bleeding?JAMA Intern Med. 2015 Mar;175(3):461. doi: 10.1001/jamainternmed.2014.7797.2015
Tsai MS, Lin CL, Hsu YC, Lee HM, Kao CH.Long-term risk of pancreatitis and diabetes after cholecystectomy in patients with cholelithiasis but no pancreatitis history: A 13-year follow-up study.Eur J Intern Med. 2015 Sep;26(7):540-4. doi: 10.1016/j.ejim.2015.06.013. Epub 2015 Jul 2.2015
Tsai MS, Li YF, Lin CL, Hsu YC, Lee PH, Sung FC, Kao CH.Long-term risk of acute coronary syndrome in patients with cholangitis: A 13-year nationwide cohort study.Eur J Intern Med. 2014 Jun;25(5):444-8. doi: 10.1016/j.ejim.2014.03.015. Epub 2014 Apr 6.2014
Hsu YC, Lin JT, Ho HJ, Kao YH, Huang YT, Hsiao NW, Wu MS, Liu YY, Wu CY.Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients.Hepatology. 2014 Apr;59(4):1293-302. doi: 10.1002/hep.26892. Epub 2014 Feb 18.2014
Liao F, Hsu YC, Kuo SH, Yang YC, Chen JP, Hsu PN, Lin CW, Chen LT, Cheng AL, Fann CS, Lin JT, Wu MS.Genetic polymorphisms and tissue expression of interleukin-22 associated with risk and therapeutic response of gastric mucosa-associated lymphoid tissue lymphoma.Blood Cancer J. 2014 Oct 10;4:eXX. doi: 10.1038/bcj.2014.70.2014
Fang YJ, Liou JM, Chen CC, Lee JY, Hsu YC, Chen MJ, Tseng PH, Chen CC, Chang CY, Yang TH, Chang WH, Wu JY, Wang HP, Luo JC, Lin JT, Shun CT, Wu MS; for the Taiwan Gastrointestinal Disease and Helicobacter Consortium.Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria.Gut. 2014 Nov 18. pii: gutjnl-2014-308114. doi: 10.1136/gutjnl-2014-308114. [Epub ahead of print]2014
Tsai MS, Hsu YC, Yu PC, Lin CL, Kao CH.Long-term risk of acute coronary syndrome in hepatitis C virus infected patients without antiviral treatment: A cohort study from an endemic area.Int J Cardiol. 2014 Nov 27;181C:27-29. doi: 10.1016/j.ijcard.2014.11.200. [Epub ahead of print]2014
Hsu YC, Wu CY, Lane HY, Chang CY, Tai CM, Tseng CH, Lo GH, Perng DS, Lin JT, Mo LR.Determinants of hepatocellular carcinoma in cirrhotic patients treated with nucleos(t)ide analogues for chronic hepatitis B.J Antimicrob Chemother. 2014 Jul;69(7):1920-7. doi: 10.1093/jac/dku041. Epub 2014 Feb 26.2014
Wu CY, Hsu YC.Antiviral therapy and hepatitis B virus-related hepatocellular carcinoma recurrence--reply.JAMA. 2013 Feb 27;309(8):766-7. doi: 10.1001/jama.2013.574.2013
Liou JM, Chen CC, Chen MJ, Chen CC, Chang CY, Fang YJ, Lee JY, Hsu SJ, Luo JC, Chang WH, Hsu YC, Tseng CH, Tseng PH, Wang HP, Yang UC, Shun CT, Lin JT, Lee YC, Wu MS; Taiwan Helicobacter Consortium.Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.Lancet. 2013 Jan 19;381(9862):205-13. doi: 10.1016/S0140-6736(12)61579-7. Epub 2012 Nov 16.2013
Hsu YC, Ho HJ, Wu MS, Lin JT, Wu CY.Postoperative peg-interferon plus ribavirin associated with reduced recurrence of hepatitis C virus-related hepatocellular carcinoma.Hepatology. 2013 Feb 6. doi: 10.1002/hep.26300. [Epub ahead of print]2013
Hsu YC, Wu CY.The association between postoperative antiviral treatment and recurrence of hepatitis C virus-related hepatocellular carcinoma.Hepatology. 2013 Aug 19. doi: 10.1002/hep.26691. [Epub ahead of print]2013
Wu CY, Chen YJ, Ho HJ, Hsu YC, Kuo KN, Wu MS, Lin JT.Association between nucleoside analogues and risk of hepatitis B virus–related hepatocellular carcinoma recurrence following liver resection.JAMA. 2012 Nov 14;308(18):1906-14.2012
Hsu YC, Lin JT, Chen TT, Wu MS, Wu CY.Long-term risk of recurrent peptic ulcer bleeding in patients with liver cirrhosis: A 10-year nationwide cohort study.Hepatology. 2012 Aug;56(2):698-705. doi: 10.1002/hep.25684. Epub 2012 Jul 6.2012
Hsu YC, Lin JT.Images in clinical medicine. Intestinal infestation with Ancylostoma ceylanicum.N Engl J Med. 2012 Mar 29;366(13):e20.2012
Hsu YC, Yang TH, Liou JM, Hsu WL, Lin HJ, Wu HT, Lin JT, Wang HP, Wu MS.Can clinical features stratify use of endoscopy for dyspeptic patients with high background prevalence of upper gastrointestinal cancer?Dig Liver Dis. 2012 Mar;44(3):218-23. Epub 2011 Nov 23.2012
Hsu YC, Chiu HM, Liou JM, Chang CC, Lin JT, Liu HH, Wu MS.Glycated hemoglobin A1c is superior to fasting plasma glucose as an independent risk factor for colorectal neoplasia.Cancer Causes Control. 2012 Feb;23(2):321-8. Epub 2011 Nov 29.2012
Hsu YC, Mo LR, Chang CY, Perng DS, Tseng CH, Lo GH, Tai CM, Lin CW, Hsu CC, Hsu CY, Huang SC, Lin JT.Entecavir versus lamivudine in the treatment of chronic hepatitis B patients with hepatic decompensation.Antivir Ther. 2012;17(4):605-12. doi: 10.3851/IMP2027. Epub 2011 Dec 20.2012
Hsu YC, Liou JM, Yang TH, Hsu WL, Lin HJ, Wu HT, Lin JT, Wang HP, Wu MS.Proton pump inhibitor versus prokinetic therapy in patients with functional dyspepsia: is therapeutic response predicted by Rome III subgroups?J Gastroenterol. 2011 Feb;46(2):183-90. Epub 2010 Oct 19.2011
Hsu YC, Chung CS, Wang HP.Application of endoscopy in improving survival of cirrhotic patients with acute variceal hemorrhage.Int J Hepatol. 2011;2011:893973. Epub 2011 Jul 21.2011